Publication | Open Access
<p>Assessment of potential predictive value of peripheral blood inflammatory indexes in 26 cases with soft tissue sarcoma treated by pazopanib: a retrospective study</p>
15
Citations
17
References
2019
Year
Low pretreatment and decrease in NLR and DNLR values, and regression/stable disease after 3 months of pazopanib are predictive factors for longer OS and PFS.
| Year | Citations | |
|---|---|---|
Page 1
Page 1